A team working at the EPFL in Lausanne and at the Vaud University Hospital say they’ve discovered an antibody which neutralizes all currently known Covid mutations.
If it proves to be successful in humans it could be used by those who have weak autoimmune systems and to treat those with a severe infection.
The researchers say the antibody locks onto a spike on the virus which is not prone to mutation and so stops it multiplying.
Clinical studies are now being planned for the end of year and there are already talks with a company to take on development and production.
Heat closes Geneva paddling pools
Soaring temps hit hospitals
Crans-Montana looks to summer season after fire tragedy
MétéoSuisse warns of budget cuts
Rents rise Geneva - more than Zurich
Better passenger rights coming
